Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

September 18, 2023

Study Completion Date

August 31, 2028

Conditions
Thoracic Aorta AneurysmAneurysm, RupturedAortic Aneurysm
Interventions
DEVICE

penetrating atherosclerotic ulcer, aorta branch cardiovascular implant

The Relay Branch System is intended to provide an option for patients with arch and proximal descending chronic thoracic aortic pathologies.

Trial Locations (12)

10032

Columbia University Medical Center, New York

19104

Hospital of the University of Pennsylvania/Penn Presbyterian, Philadelphia

21201

University of Maryland, Baltimore

27710

Duke University, Durham

30322

Emory University, Atlanta

32608

University of Florida, Gainesville

44195

Cleveland Clinic, Cleveland

63110

Barnes Jewish Hospital at Washington University, St Louis

75093

Baylor Scott and White Research Institute, Plano

77030

Baylor College of Medicine, Houston

90033

University of Southern California, Los Angeles

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bolton Medical

INDUSTRY

NCT03214601 - Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System | Biotech Hunter | Biotech Hunter